References

Aliabadi, F.S. and P. Lees, 2001. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. Am. J. Vet. Res., 62: 1979-1989.
PubMed  |  

Aliabadi, F.S. and P. Lees, 2003. Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf. Res. Vet. Sci., 74: 247-259.
CrossRef  |  PubMed  |  Direct Link  |  

Aliabadi, F.S., B.H. Ali, M.F. Landoni and P. Lees, 2003. Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids. Vet. J., 165: 104-118.
CrossRef  |  Direct Link  |  

Aliabadi, F.S., M.F. Landoni and P. Lees, 2003. Pharmacokinetics (PK), pharmacodynamics (PD) and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrob. Agents Chemother., 47: 626-635.
CrossRef  |  

Craig, W.A. and S.C. Ebert, 1990. Killing and regrowth of bacteria in vitro: A review. Scand. J. Infect. Dis. Suppl., 74: 63-70.

Fernandez-Varon, E., M.J. Bovaira, A. Espuny, E. Escudero, D. Vancraeynest and C.M. Carceles, 2005. Pharmacokinetic-pharmacodynamic integration of Moxifloxacin in rabbits after intravenous, intramuscular and oral administration. J. Vet. Pharmacol. Ther., 28: 343-348.
CrossRef  |  Direct Link  |  

Fernandez-Varon, E., P. Marin, E. Escudero, D. Vancraeynest and C.M. Carceles, 2007. Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits. J. Vet. Pharmacol. Therapeutics, 30: 18-24.
CrossRef  |  

Gibaldi, M. and D. Perrrier, 1982. Pharmacokinetics 1982. 2nd Edn., Marcel Dekker, New York, USA.,.

Gustafsson, I., E. Lowdin, I. Odenholt and O. Cars, 2002. Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model. Antimicrob. Agents Chemother., 45: 2436-2440.
CrossRef  |  Direct Link  |  

Haritova, A.M., N.V. Rusenova, P.R. Parvanov, L.D. Lashev and J. Fink-Gremmels, 2006. Pharmacokinetic-pharmacodynamic modelling of danofloxacin in Turkeys. Vet. Res. Commun., 30: 775-789.
CrossRef  |  

Lindecrona, R.H., C. Friis and N.E. Jensen, 2002. The pharmacodynamic effect of amoxycillin and danofloxacin against Actinobacillus pleuropneumoniae in an in-vitro pharmacodynamic model. Res. Vet. Sci., 67: 93-97.
CrossRef  |  Direct Link  |  

Mckellar, Q.A., S.F.S. Bruni and D.G. Jones, 2004. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. J. Vet. Pharmacol. Ther., 27: 503-514.
PubMed  |  

Sarasola, P., P. Lees, F.S. AliAbadi, Q.A. McKella and W. Donachie et al., 2002. Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica. Antimicrob. Agents Chemother., 46: 3013-3019.
PubMed  |  

Toutain, P.L. and P. Lees, 2004. Integration and modeling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. J. Vet. Pharm. Therap., 27: 467-477.
PubMed  |  

Xia, W.J. and Z.R. Chen, 1988. [MCPKP-A computer program on analyzing compartment model (In Chinese)]. Acta Pharmacol. Sinica, 9: 188-192.

Zeng, Z.L., 2002. Bioavailatility and pharmacokinetics of amoxicillin sodium in pigs. Acta Veterinaria Zootechnica Sinica, 33: 594-597.